Holen Sie sich die Stockscreener-App
2.44
0.83%
0.02
Handel nachbörslich:
2.44
Finanzdaten der Alzamend Neuro Inc-Aktie (ALZN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
9.79%
1.1389
|
1.0374 | 1.3581 | 0.9624 | 0.8501 |
| Interest Income/Expense |
74.79%
0.000509
|
0.00202 | 0.0035 | 0.012 | 0.00147 |
| Operating Income/Loss |
9.79%
-1.1389
|
-1.0374 | -1.3581 | -0.9624 | -0.8501 |
| Nonoperating Income/Loss |
74.79%
-0.000509
|
-0.00202 | -0.0035 | -0.012 | -0.00147 |
| Income/Loss From Continuing Operations Before Tax |
9.62%
-1.1394
|
-1.0394 | -1.3616 | 1.00 | -19.05 |
| Income/Loss From Continuing Operations After Tax |
9.62%
-1.1394
|
-1.0394 | -1.3616 | 1.00 | -19.05 |
|
Net Income/Loss
|
857.66%
7.8754
|
-1.0394 | -1.3616 | 1.00 | 0.80 |
| Preferred Stock Dividends And Other Adjustments |
0.5902
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
9.0149
|
- | 0.0537 | 1.9744 | 1.6515 |
| Basic Average Shares |
151.20%
-2.825
|
5.5178 | 3.5317 | 0.7778 | -6.0504 |
| Diluted Average Shares |
151.20%
-2.825
|
5.5178 | 3.5317 | 0.7778 | -6.0504 |
| Basic Earnings Per Share |
5,316%
-10.29
|
-0.19 | -0.40 | -1.25 | -13.35 |
| Diluted Earnings Per Share |
5,316%
-10.29
|
-0.19 | -0.40 | -1.25 | -13.35 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.5902
|
- | - | - | - |
0.95%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):